Eszopiclone
NDC Package 50436-5539-1
Package Information
Eszopiclone is a medication used to treat a certain sleep problem (insomnia). Marketed by Unit Dose Services, this product is identified by NDC 50436-5539 and is authorized under FDA application ANDA091169.
Identification & Billing
- RxCUI: 485442 - eszopiclone 2 MG Oral Tablet
- RxCUI: 485465 - eszopiclone 3 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 50436 - Unit Dose Services
- 50436-5539 - Eszopiclone
- 50436-5539-1 - 30 TABLET, FILM COATED in 1 BOTTLE
- 50436-5539 - Eszopiclone
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 50436-5539-1 identifies a specific commercial package of 30 tablet, film coated in 1 bottle of Eszopiclone, labeled by Unit Dose Services. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Unit Dose Services on April 14, 2014. The current certification is valid through December 31, 2020.
What are the primary indications for this medication?
This medication is used to treat a certain sleep problem (insomnia). It may help you fall asleep faster, stay asleep longer, and lessen how often you wake up during the night, so you can get a better night's rest. Eszopiclone belongs to a class of drugs called sedative-hypnotics. It acts on your brain to produce a calming effect. Use of this medication is usually limited to short treatment periods of 1 to 2 weeks or less. If your insomnia continues for a longer time, talk to your doctor to see if you need other treatment.
How is this Unit Dose Services product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 50436553901. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.